WIRE)–GE Healthcare announced today a long-term agreement with Biosense
Webster, Inc., in which the companies will co-distribute their leading
electrophysiology (EP) systems – including GEs CardioLab* EP Recording Systems
and Biosense Websters CARTO® 3 navigation system – in the United States, and
will collaborate to enhance the functional integration of their recording,
imaging and 3D mapping systems.
“GE Healthcare is committed to becoming a total EP lab
solution provider as we work to meet the clinical and workflow needs of
electrophysiologists. The arrangement with Biosense Webster moves GE Healthcare
closer to realizing that vision by enabling us to provide our U.S. customers
with a more comprehensive portfolio of EP products than any single company can
provide,” said Jean-Michel Milles, General Manager of Interventional
Electrophysiology, GE Healthcare.
ABOUT GE HEALTHCARE:
GE Healthcare provides transformational medical technologies and services that
are shaping a new age of patient care. Our broad expertise in medical
imaging and information technologies, medical diagnostics, patient monitoring
systems, drug discovery, biopharmaceutical manufacturing technologies, performance
improvement and performance solutions services help our
customers to deliver better care to more people around the world at a
lower cost. In addition, we partner with healthcare leaders, striving
to leverage the global policy change necessary to implement a
successful shift to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the
world to join us on our journey as we continuously develop innovations
focused on reducing costs, increasing access and improving quality around
the world. Headquartered in the United
Kingdom, GE Healthcare is a unit of General
Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are
committed to serving healthcare professionals and their patients in more than
100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
Posted by Sean Fenske, Editor-in-Chief, MDT